Serina Therapeutics Statistics
Total Valuation
SER has a market cap or net worth of $41.69 million. The enterprise value is $20.50 million.
| Market Cap | 41.69M |
| Enterprise Value | 20.50M |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SER has 15.00 million shares outstanding. The number of shares has increased by 18.27% in one year.
| Current Share Class | 15.00M |
| Shares Outstanding | 15.00M |
| Shares Change (YoY) | +18.27% |
| Shares Change (QoQ) | +12.97% |
| Owned by Insiders (%) | 67.19% |
| Owned by Institutions (%) | 2.79% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 320.72 |
| Forward PS | n/a |
| PB Ratio | 3.26 |
| P/TBV Ratio | 3.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 157.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.18 |
| Quick Ratio | 3.87 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.18 |
Financial Efficiency
Return on equity (ROE) is -221.93% and return on invested capital (ROIC) is -133.22%.
| Return on Equity (ROE) | -221.93% |
| Return on Assets (ROA) | -89.79% |
| Return on Invested Capital (ROIC) | -133.22% |
| Return on Capital Employed (ROCE) | -86.66% |
| Weighted Average Cost of Capital (WACC) | 4.62% |
| Revenue Per Employee | $8,125 |
| Profits Per Employee | -$1.35M |
| Employee Count | 16 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SER has paid $25,000 in taxes.
| Income Tax | 25,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.55% in the last 52 weeks. The beta is -0.00, so SER's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -49.55% |
| 50-Day Moving Average | 2.03 |
| 200-Day Moving Average | 2.45 |
| Relative Strength Index (RSI) | 76.65 |
| Average Volume (20 Days) | 41,876 |
Short Selling Information
The latest short interest is 284,546, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 284,546 |
| Short Previous Month | 383,983 |
| Short % of Shares Out | 1.90% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.05 |
Income Statement
In the last 12 months, SER had revenue of $130,000 and -$21.56 million in losses. Loss per share was -$2.00.
| Revenue | 130,000 |
| Gross Profit | -13.27M |
| Operating Income | -24.44M |
| Pretax Income | -21.27M |
| Net Income | -21.56M |
| EBITDA | -17.89M |
| EBIT | -18.16M |
| Loss Per Share | -$2.00 |
Balance Sheet
The company has $24.53 million in cash and $3.34 million in debt, with a net cash position of $21.19 million or $1.41 per share.
| Cash & Cash Equivalents | 24.53M |
| Total Debt | 3.34M |
| Net Cash | 21.19M |
| Net Cash Per Share | $1.41 |
| Equity (Book Value) | 17.63M |
| Book Value Per Share | 0.85 |
| Working Capital | 20.13M |
Cash Flow
In the last 12 months, operating cash flow was -$18.20 million and capital expenditures -$84,000, giving a free cash flow of -$18.29 million.
| Operating Cash Flow | -18.20M |
| Capital Expenditures | -84,000 |
| Depreciation & Amortization | 74,000 |
| Net Borrowing | 4.91M |
| Free Cash Flow | -18.29M |
| FCF Per Share | -$1.22 |
Margins
| Gross Margin | n/a |
| Operating Margin | -18,803.08% |
| Pretax Margin | -16,358.46% |
| Profit Margin | n/a |
| EBITDA Margin | -13,763.08% |
| EBIT Margin | -13,972.31% |
| FCF Margin | n/a |
Dividends & Yields
SER does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.27% |
| Shareholder Yield | -18.27% |
| Earnings Yield | -51.71% |
| FCF Yield | -43.86% |
Analyst Forecast
The average price target for SER is $9.50, which is 241.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.50 |
| Price Target Difference | 241.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SER has an Altman Z-Score of -2.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.92 |
| Piotroski F-Score | 4 |